Prefilled Syringes to 2018 Devices, Drugs, Markets, Players

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Prefilled Syringes to 2018 Devices, Drugs, Markets, Players and Prospects

Dublin, Nov. 6, 2013 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/hrkt3j/prefilled ) has announced the addition of the "Prefilled Syringes to 2018 Devices, Drugs, Markets, Players and Prospects" report to their offering.

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery. For Fill-and-Finish contractors, market proximity is an important competitive factor. As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefilled syringes advancing commercially.

This report analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.

Highlights

  • Provides detailed analysis of prefilled syringe market segments, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments
  • Examines design factors, material selection issues, technologies and market development issues
  • Charts product data, market share, and forecasts to 2018
  • Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Key Topics Covered

Executive Summary

Injectable Drug Market Dynamics

The Prefilled Syringe Ecosystem and Supply Chain

Prefilled Syringes - Design Factors

Prefilled Syringes - Commercial Devices

Prefillable Therapeutic Injectables

Specialty Prefillable Syringes

Competing Prefilled Devices

Prefilled Syringe Market Segments

Prefilled Therapeutic Injectables

Non-API Prefilled Syringe Segments

Market Factors

Prefilled Syringes - Market Participant Profiles

For more information visit http://www.researchandmarkets.com/research/hrkt3j/prefilled

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Sales Focus Inc. Awarded as Leading Medical Outsourcing Service

Updated Category News Views 112

Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...

Continue Reading
The Rise of Autonomous Data Platforms in the Tech Industry

Updated Category News Views 76

Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....

Continue Reading
Enpro's Recent Insider Activity Signals Strong Future Potential

Updated Category News Views 177

Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...

Continue Reading
Massive Increase in BNB Fund for Cancer Patients Unveiled

Updated Category News Views 168

BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...

Continue Reading
Bio X Cell Refreshes Brand Identity to Enhance Global Research Impact

Updated Category News Views 171

Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...

Continue Reading